Approvals/TGA/NAGLAZYME galsulfase-rch 5mg/5mL concentrated solution for injection vial

Approved

STANDARD

NAGLAZYME galsulfase-rch 5mg/5mL concentrated solution for injection vial

Approval Id: 3a9c6709c71442b0
Product Name: NAGLAZYME galsulfase-rch 5mg/5mL concentrated solution for injection vial
Artg Id: 125598
Artg Name: NAGLAZYME galsulfase-rch 5mg/5mL concentrated solution for injection vial
Sponsor: BioMarin Pharmaceutical Australia Pty Ltd
Company Detail Path: /organization/biomarin-pharmaceutical-australia-pty-ltd
Artg Date: 2007-03-20
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/408b4af69dc9b5a6d9cd46f0316a1296.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/4a548e912ddaff26d094cb2c346e88f9.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

3a9c6709c71442b0

Type

Standard